Acutaas Chemicals Limited vs Divi's Laboratories Limited

A side-by-side comparison of Acutaas Chemicals Limited (ACUTAAS) and Divi's Laboratories Limited (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Acutaas Chemicals Limited vs Divi's Laboratories Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation13
  • Profitability40
  • Growth20
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

DIVISLAB takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

73.73
P/E ratio
94.52
17.09
P/B ratio
14.90
0.07%
Dividend yield
0.32%
₹43.51
EPS
₹96.75

Profitability

ACUTAAS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

21.54%
Return on equity
15.32%
28.77%
Return on capital
20.35%
35.87%
EBITDA margin
32.59%
26.61%
Net margin
24.32%

Growth

ACUTAAS takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

29.50%
Revenue CAGR (3Y)
10.78%
62.34%
Profit CAGR (3Y)
12.09%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹26,224 Cr
Market cap
₹2.45L Cr
₹1,339 Cr
Revenue
₹10,560 Cr
₹356 Cr
Net profit
₹2,568 Cr
0.02
Debt / equity
0.00
Acutaas Chemicals Limited
  • + ["Company has delivered good profit growth of 45.8% CAGR over last 5 years", "Company is almost debt free.", "Company has delivered good sales growth of 31.5% CAGR over last 5 years"]
  • − ["Stock is trading at 15.87 times its book value"]
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.48 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Acutaas Chemicals Limited full analysis Divi's Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.